Hepatitis C and HIV

Unfortunately a high percentage of those affected with HIV are also infected with the Hepatitis C virus. It is believed that nearly forty percent of HIV sufferers also have HCV.  This is because both viruses are transmitted the same way. They can be passed along by the shared use of needles or other drug paraphernalia or by unprotected sex because they are both transferred by blood-to-blood transmissions.   This means that it is not a surprise that people will be coinfected, having both infections, but it definitely makes treating them more difficult. Especially since Hepatitis C., also known as HCV, makes HIV worse, though it is known that it does not interfere with the medications used to treat HIV.

Studies conducted on people who are coinfected have found that this group seems to suffer a higher proportion of cases of depression, not a surprise when you think of what they have to deal with in their lives. The concern is that those who are feeling this way may be more apt to mix up their medications or even forget to take them.

One of the most difficult treatment issues with someone who is coinfected can be which should be treated first the HIV or the HCV? This must be decided based on severity and the progress of each infection. If the Hepatitis C is showing only mild symptoms then the HIV should be treated first. Leaving HIV untreated for six months to a year could be very hard on the patient's body and could lead to further complications down the way. On the other hand if the cell counts are high enough and the HCV is problematic then treating the hepatitis would be helpful in the long run. This is especially true because the liver will then be able to deal better with the strong drugs that need to be taken for HIV.

Those who are coinfected are at risk for the Hepatitis C virus to be much worse than others who are fighting only the one virus. With both, the patient may find that serious liver disease progresses much faster. Liver failure can actually occur.  Drug therapy for those who are coinfected is successful twenty five to fifty percent of the time depending on which genotype the HCV is. The results are better with type two and three then type one.  The drugs that are necessary to treat HIV can be very hard on the liver and so make for one more reason that trying to treat the HCV is very important.

When someone is coinfected the viral levels of the hepatitis are much higher. This means that the spread of the infection becomes that much easier and so the patient must work harder to control this potential for spreading. Do not share anything that may have even the minutest amount of blood on it. That includes toothbrushes, facecloths or razors.
If you're coinfected, or someone you love is, be sure the physician is able to treat you for both these difficult viruses.

Hepatitis news on the Web

Hepatitis Research May Benefit From Stem Cells
Hepatitis C is a viral disease that leads to inflammation and organ failure. However, researchers are puzzled as to why some individuals are very susceptible to the disease, while others are not. Researchers believe they could find out how genetic variations produce these different responses by investigating liver cells from different individuals in the lab. However, liver cells are hard to ...

Gilead Sciences jumps on hepatitis C data
Shares of Gilead Sciences Inc. jumped Friday after the company reported further progress of GS-7977, a newly-acquired hepatitis C treatment still in clinical testing.THE SPARK: Gilead said Thursday that ...

Gilead Rises on Hepatitis C Trial Results: San Francisco Mover
Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc. last month for its experimental hepatitis C treatments, gained the most in three years after one of the medicines produced positive clinical trial results.

Township hosting hepatitis B vaccine clinics
WEST MILFORD Hepatitis is one of the most harmful diseases one can have, many times leading into liver cancer years down the road. The West Milford Health Department is promoting a series of three hepatitis B vaccines to protect your liver from this devastating disease.

Gilead Gains on Positive Data From Experimental Hepatitis C Drug
Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc. last month for its experimental hepatitis C treatments, gained in extended trading after saying one of the therapies produced positive clinical trial results.

Stem cells could drive hepatitis research forward
Researchers have produced liver-like cells from induced pluripotent stem cells. By creating liver-like cells, scientists can study why people respond differently to Hepatitis C.

Stem Cells May Further Hepatitis C Research
Title: Stem Cells May Further Hepatitis C Research Category: Health News Created: 1/31/2012 4:05:00 PM Last Editorial Review: 2/1/2012

U.S. hepatitis A vaccine rates vary widely, survey shows
NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC). In certain states, particularly those in the south, midwest and eastern U.S., those rates are lower -- with about three kids out of 10 ...

Research and Markets: Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016
Research and Markets has announced the addition of the "Hepatitis C Market Forecast & Drugs Pipeline A

Hepatitis C treatment with antivirals is effective
A major advance in treating hepatitis C appears to be on the horizon. Researchers reported Wednesday that combining two antiviral medications was effective in stopping the infection in some patients who were not helped by the traditional treatment.